Can a new pill silence stubborn hives?
Disease control
Not yet recruiting
This trial is testing an experimental oral medication called THB335 in adults with chronic spontaneous urticaria (CSU), a condition marked by persistent hives and itching that standard antihistamines don't fully control. Participants will take THB335 or a placebo alongside their …
Phase: PHASE2 • Sponsor: Calixis Inc. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC